News
A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...
This was the stock's second consecutive day of losses.
Key Takeaways Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for ...
Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...
Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...
Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...
Explore more
Medical analysis equipment maker Waters is combining with a unit of Becton Dickinson in a complex spin-merge. At a discount ...
Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” second quarter 2025 ...
Becton Dickinson & Co. closed 29.02% below its 52-week high of $251.99, which the company reached on February 3rd.
Universal Health Realty's dividend has been hiked annually for four decades. That's a pretty good streak, even though it ...
Becton Dickinson said production of its recently approved rapid test for the coronavirus strain Covid-19 will ramp up to 12 million tests per month by the end of February 2021.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results